VIDA is a precision lung health company, accelerating therapies to patients through AI-powered lung intelligence. VIDA Discovery services enable more efficient respiratory clinical trials by providing more precise quantitative endpoints, AI-powered data quality controls, site training, and more to help biopharma sponsors save millions in drug development costs. VIDA Insights empowers physicians to better manage patients with or at risk of chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), asthma, emphysema, lung cancer, COVID-19 and more.